NanoBio Corp.

NanoBio Closes $11 Million Series C FinancingNanoBio Corp. announced Wednesday the closing of an $11 million Series C financing, including full participation from its existing investor syndicate.
NanoBio To Present Data On RSV VaccineNanoBio Corp. said it will present data from two separate preclinical studies at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy meeting this week in San Francisco.